Table 1.

Patients’ characteristics.

Case	Age	Sex	Past history	Symptom	aPTT (sec)	FVIII (%)	Inhibitor against FVIII (BU/mL)	Treatment treatment	Current
1	75	Female	Colon cancer	Hematoma	113.8	<1	2070	rFVIIa/PSL/CSA/Rituximab	PSL
2	80	Male	Colon cancer	Subcutaneous bleeding	82	<1	1587	PSL	PSL/CSA
3	66	Female	Breast cancer	No symptom	62.3	26	-	PSL	PSL
4	63	Female	Scleroderma	Subcutaneous bleeding	113.3	<1	36.7	PSL	PSL
5	34	Female	RA/pregnancy/placenta previa	Hematuria	104.5	<1	174	PSL	PSL
6	48	Male	Prior bleeding episode	Hematoma	66.9	24	0.7	rFVIIa/PSL	PSL

RA: rheumatoid arthritis, aPTT: activated partial thromboplastin time, FVIII: factor VIII, rFVIIa: recombinant factor VIIa.